CoChat

Iron chelation therapy for myelodysplastic syndrome: a systematic review and meta-analysis

Liu, Hailing, Yang, Nan, Meng, Shan, Zhang, Yang, Zhang, Hui, Zhang, Wanggang · 2020 · Clinical and Experimental Medicine

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Abstract

Iron overload remains a concern in myelodysplastic syndrome (MDS) patients especially those requiring recurrent blood transfusions. Whether iron chelating therapy (ICT) is beneficial to the long-term survival of myelodysplastic syndrome is still a controversial issue. Therefore, we conducted a systematic review and meta-analysis to clarify the relationship between ICT and long-term survival in patients with MDS. A total of 14 studies involving 7242 participants were identified; the outcomes revealed that for patients with MDS, ICT resulted in a lower risk of mortality compared to those with no ICT (HR 0.57; 95% CI 0.44-0.70; P < 0.001); what is more, ICT led to a lower risk of leukemia transformation (HR 0.70; 95% CI 0.52-0.93; P = 0.016). Results of subgroup analyses based on adequate ICT or any ICT, low/int-1 IPSS or unclassified IPSS and study types indicated that the ICT had a beneficial role in all these groups of patients.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10238-019-00592-5

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Cited by

See all 13

Metadata

Authors
Liu, H., Yang, N., Meng, S., Zhang, Y., Zhang, H., & Zhang, W.
Affiliations
Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Corresponding author
Zhang, Wanggang
Venue
Clinical and Experimental Medicine
Published
2019-11-11
Volume
20
Issue
1
Pages
1-9
ISSN
  • 1591-8890 (ISSN-L)
  • 1591-9528
OpenAlex
W2988761910
Cited by
13
References
47
Citations by year
2025: 3 · 2023: 1 · 2021: 6 · 2020: 3
FWCI
0.36
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Clinical and Experimental Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Shaanxi International Scientific Research Cooperation and Exchange Program (2016KW-020)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
Keywords
iron chelation therapy, myelodysplastic syndrome, iron overload, blood transfusion, mortality, leukemic transformation, long-term survival, International Prognostic Scoring System, subgroup analysis
MeSH terms
Humans, Iron, Myelodysplastic Syndromes, Chelation Therapy, Survival Analysis, Treatment Outcome, Iron Overload

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Iron chelation therapy for myelodysplastic syndrome: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1007/s10238-019-00592-5
The paper
Liu, H., Yang, N., Meng, S., Zhang, Y., Zhang, H., & Zhang, W. (2020). Iron chelation therapy for myelodysplastic syndrome: a systematic review and meta-analysis. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-019-00592-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.